NASDAQ : LFCR
Lifecore Biomedical, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 6.4 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 242.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Lifecore Biomedical, Inc. (LFCR) reported revenue of 129.46M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 129.46M | 129.46M | 128.87M | 128.26M | 103.27M | 111.27M |
| Cost of Revenue | 88.85M | 88.85M | 88.57M | 86.41M | 75.28M | 72.20M |
| Gross Profit | 40.61M | 40.61M | 40.30M | 41.85M | 27.98M | 39.07M |
| Selling, General & Admin | 33.35M | 33.35M | 44.05M | 38.76M | 38.97M | 34.66M |
| Research & Development | 8.51M | 8.51M | 8.26M | 8.57M | 8.74M | 7.84M |
| Operating Expenses | 41.87M | 41.87M | 52.30M | 47.34M | 47.70M | 42.50M |
| Operating Income | -1.26M | -1.26M | -12.01M | -5.49M | -19.72M | -3.43M |
| Interest Expense | -27.17M | -27.17M | -22.17M | -18.15M | -17.58M | -15.47M |
| Interest & Investment Income | 468.00K | 468.00K | 333.00K | 58.00K | ||
| Other Non Operating Income (Expenses) | -2.26M | -2.26M | 406.00K | 36.45M | -810.00K | 6.57M |
| EBT Excluding Unusual Items | -30.21M | -30.21M | -33.44M | 12.87M | -38.11M | -12.33M |
| Merger & Restructuring Charges | 1.75M | -1.66M | -4.18M | -8.36M | ||
| Gain (Loss) on Sale of Assets | -6.99M | 2.11M | ||||
| Other Unusual Items | -1.70M | -23.74M | ||||
| Pretax Income | -30.21M | -30.21M | -38.67M | 9.51M | -63.93M | -20.69M |
| Income Tax Expense | 577.71K | 577.71K | 43.00K | 183.00K | 308.00K | -5.21M |
| Earnings From Continuing Operations | -30.79M | -30.79M | -38.72M | 9.33M | -64.24M | -15.48M |
| Earnings From Discontinued Operations | 2.68M | -35.33M | -101.24M | |||
| Net Income to Company | -30.79M | -30.79M | -38.72M | 12.01M | -99.56M | -116.72M |
| Net Income | -30.79M | -30.79M | -38.72M | 12.01M | -99.56M | -116.72M |
| Preferred Dividends & Other Adjustments | 3.71M | 3.71M | 5.64M | |||
| Net Income to Common | -34.50M | -34.50M | -44.36M | 12.01M | -99.56M | -116.72M |
| Shares Outstanding (Basic) | 37.37M | 37.37M | 34.82M | 30.47M | 29.96M | 29.47M |
| Shares Outstanding (Diluted) | 37.37M | 37.37M | 34.82M | 36.66M | 29.96M | 29.47M |
| EPS (Basic) | -0.92 | -0.92 | -1.27 | 0.39 | -3.32 | -3.96 |
| EPS (Diluted) | -0.93 | -0.93 | -1.27 | 0.33 | -3.32 | -3.97 |
| Free Cash Flow | 6.23M | 6.23M | -13.62M | -18.14M | -38.92M | -52.53M |
| Free Cash Flow Per Share | 0.17 | 0.17 | -0.39 | -0.49 | -1.30 | -1.78 |
| Gross Margin | 31.37% | 31.37% | 31.27% | 32.63% | 27.10% | 35.11% |
| Operating Margin | -0.97% | -0.97% | -9.32% | -4.28% | -19.10% | -3.08% |
| Profit Margin | -26.65% | -26.65% | -34.42% | 9.37% | -96.41% | -104.89% |
| Free Cash Flow Margin | 4.81% | 4.81% | -10.57% | -14.14% | -37.69% | -47.21% |
| EBITDA | 8.24M | 8.24M | -3.98M | 2.47M | -7.04M | 14.23M |
| EBITDA Margin | 6.37% | 6.37% | -3.09% | 1.92% | -6.82% | 12.79% |
| D&A For EBITDA | 9.50M | 9.50M | 8.03M | 7.95M | 12.68M | 17.66M |
| EBIT | -1.26M | -1.26M | -12.01M | -5.49M | -19.72M | -3.43M |
| EBIT Margin | -0.97% | -0.97% | -9.32% | -4.28% | -19.10% | -3.08% |
| Effective Tax Rate | 1.92% | |||||
| Revenue as Reported | 129.46M | 129.46M | 128.87M | 128.26M | 103.27M | 111.27M |
| Advertising Expenses | 5.10K | 5.60K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 17.47M | 17.47M | 8.27M | 8.46M | 19.09M | 991.00K |
| Cash & Short-Term Investments | 17.47M | 17.47M | 8.27M | 8.46M | 19.09M | 991.00K |
| Accounts Receivable | 33.82M | 33.82M | 35.67M | 31.15M | 29.02M | 38.31M |
| Receivables | 33.82M | 33.82M | 43.67M | 31.15M | 29.02M | 38.31M |
| Inventory | 29.09M | 29.09M | 32.29M | 39.98M | 40.84M | 36.00M |
| Prepaid Expenses | 1.92M | 1.92M | 1.45M | 1.44M | 4.02M | 1.05M |
| Other Current Assets | 900.00K | 40.31M | ||||
| Total Current Assets | 82.29M | 82.29M | 85.68M | 81.03M | 93.88M | 116.67M |
| Property, Plant & Equipment | 122.31M | 122.31M | 123.48M | 126.36M | 138.67M | 124.22M |
| Goodwill | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M |
| Other Intangible Assets | 4.20M | 4.20M | 4.20M | 4.20M | ||
| Long-Term Deferred Charges | 1.40M | |||||
| Other Long-Term Assets | 9.49M | 9.49M | 16.30M | 32.68M | 1.52M | 15.73M |
| Total Assets | 232.18M | 232.18M | 239.34M | 253.96M | 253.54M | 274.70M |
| Accounts Payable | 5.84M | 5.84M | 8.22M | 16.33M | 22.10M | 12.95M |
| Accrued Expenses | 6.25M | 6.25M | 8.38M | 10.50M | 11.29M | 15.42M |
| Short-Term Debt | 40.00M | |||||
| Current Portion of Long-Term Debt | 773.00K | 773.00K | 3.27M | 773.00K | 580.00K | 98.18M |
| Current Portion of Leases | 553.00K | 553.00K | 551.00K | 4.13M | 1.27M | 4.37M |
| Current Unearned Revenue | 8.66M | 8.66M | 3.42M | 2.11M | 4.05M | 919.00K |
| Other Current Liabilities | 1.50M | 1.50M | 6.34M | 5.02M | 4.74M | |
| Total Current Liabilities | 23.57M | 23.57M | 30.18M | 38.87M | 39.29M | 176.58M |
| Long-Term Debt | 129.79M | 129.79M | 114.82M | 113.36M | 101.06M | |
| Long-Term Leases | 12.61M | 12.61M | 12.18M | 10.37M | 9.71M | 7.66M |
| Long-Term Unearned Revenue | 2.94M | |||||
| Long-Term Deferred Tax Liabilities | 380.00K | 126.00K | ||||
| Other Long-Term Liabilities | 32.14M | 32.14M | 34.73M | 37.46M | 65.07M | 2.52M |
| Total Liabilities | 198.12M | 198.12M | 191.91M | 200.06M | 218.46M | 186.88M |
| Common Stock | 37.00K | 37.00K | 37.00K | 31.00K | 30.00K | 30.00K |
| Additional Paid-In Capital | 208.96M | 208.96M | 206.54M | 177.81M | 174.28M | 167.35M |
| Retained Earnings | -223.20M | -223.20M | -205.24M | -166.52M | -178.54M | -78.97M |
| Comprehensive Income & Other | -586.00K | |||||
| Total Common Equity | -14.20M | -14.20M | 1.34M | 11.31M | -4.23M | 87.82M |
| Shareholders' Equity | 34.06M | 34.06M | 47.43M | 53.90M | 35.09M | 87.82M |
| Total Liabilities & Equity | 232.18M | 232.18M | 239.34M | 253.96M | 253.54M | 274.70M |
| Total Debt | 143.73M | 143.73M | 130.82M | 128.63M | 112.62M | 150.20M |
| Net Cash (Debt) | -126.26M | -126.26M | -122.56M | -120.17M | -93.53M | -149.21M |
| Net Cash Per Share | -3.38 | -3.38 | -3.52 | -3.28 | -3.12 | -5.06 |
| Filing Date Shares Outstanding | 37.48M | 37.48M | 37.41M | 30.90M | 30.55M | 29.60M |
| Total Common Shares Outstanding | 37.48M | 37.48M | 37.03M | 30.56M | 30.32M | 29.51M |
| Working Capital | 58.72M | 58.72M | 55.50M | 42.16M | 54.59M | -59.91M |
| Book Value Per Share | -0.38 | -0.38 | 0.04 | 0.37 | -0.14 | 2.98 |
| Tangible Book Value | -32.28M | -32.28M | -12.54M | -2.57M | -22.31M | 69.74M |
| Tangible Book Value Per Share | -0.86 | -0.86 | -0.34 | -0.08 | -0.74 | 2.36 |
| Land | 3.49M | 3.49M | 3.74M | 3.74M | 3.74M | 3.71M |
| Buildings | 82.02M | 82.02M | 63.73M | 62.87M | 56.79M | 54.56M |
| Machinery | 91.41M | 91.41M | 71.19M | 70.93M | 77.36M | 72.55M |
| Construction In Progress | 4.54M | 4.54M | 42.23M | 39.15M | 45.59M | 26.89M |
| Leasehold Improvements | 4.02M | 4.02M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -30.79M | -30.79M | -38.72M | 12.01M | -99.56M | -116.72M |
| Depreciation & Amortization | 9.50M | 9.50M | 8.03M | 7.95M | 12.68M | 17.66M |
| Other Amortization | 500.00K | 400.00K | ||||
| Loss (Gain) From Sale of Assets | 7.78M | 18.00K | -2.07M | 152.00K | ||
| Asset Writedown & Restructuring Costs | 640.00K | 5.18M | ||||
| Stock-Based Compensation | 9.72M | 9.72M | 10.16M | 6.20M | 3.61M | 2.61M |
| Provision & Write-off of Bad Debts | 163.00K | -14.00K | ||||
| Other Operating Activities | 29.45M | 29.45M | 17.25M | -22.23M | 24.53M | -7.25M |
| Change in Accounts Receivable | 2.76M | 2.76M | -5.17M | -2.39M | 10.82M | -6.14M |
| Change in Inventory | 5.50M | 5.50M | 7.69M | 862.00K | -14.81M | -2.18M |
| Change in Accounts Payable | -2.98M | -2.98M | -1.67M | -6.68M | 16.04M | 9.34M |
| Change in Unearned Revenue | 6.08M | -18.00K | ||||
| Change in Other Net Operating Assets | -10.59M | -10.59M | -5.54M | 4.51M | 1.66M | -4.11M |
| Operating Cash Flow | 12.57M | 12.57M | -206.00K | 257.00K | -17.44M | -22.59M |
| Capital Expenditures | -6.34M | -6.34M | -13.41M | -18.39M | -21.48M | -29.94M |
| Sale of Property, Plant & Equipment | 17.14M | 17.14M | 7.00M | 1.14M | ||
| Divestitures | 16.67M | 73.50M | ||||
| Other Investing Activities | 35.26M | |||||
| Investing Cash Flow | 10.81M | 10.81M | -6.42M | -18.39M | -4.81M | 79.96M |
| Long-Term Debt Issued | 128.57M | 149.59M | 181.45M | 75.11M | ||
| Total Debt Issued | 104.79M | 104.79M | 128.57M | 149.59M | 181.45M | 75.11M |
| Long-Term Debt Repaid | -145.76M | -146.70M | -178.33M | -130.52M | ||
| Total Debt Repaid | -109.07M | -109.07M | -145.76M | -146.70M | -178.33M | -130.52M |
| Net Debt Issued (Repaid) | -4.29M | -4.29M | -17.19M | 2.88M | 3.12M | -55.41M |
| Issuance of Common Stock | 23.85M | 4.82M | ||||
| Repurchase of Common Stock | -1.94M | -1.94M | -1.27M | -152.00K | -274.00K | -789.00K |
| Other Financing Activities | -1.37M | -1.37M | 1.03M | 4.78M | -6.05M | -821.00K |
| Financing Cash Flow | -7.59M | -7.59M | 6.42M | 7.51M | 39.70M | -57.02M |
| Net Cash Flow | 15.78M | 15.78M | -197.00K | -10.63M | 17.45M | 348.00K |
| Free Cash Flow | 6.23M | 6.23M | -13.62M | -18.14M | -38.92M | -52.53M |
| Free Cash Flow Margin | 4.81% | 4.81% | -10.57% | -14.14% | -37.69% | -47.21% |
| Free Cash Flow Per Share | 0.17 | 0.17 | -0.39 | -0.49 | -1.30 | -1.78 |
| Levered Free Cash Flow | -29.04M | -20.27M | 16.29M | -26.82M | ||
| Unlevered Free Cash Flow | -15.19M | -8.93M | 27.28M | -17.15M | ||
| Cash Interest Paid | 2.52M | 2.52M | 1.91M | 2.73M | 31.02M | 16.89M |
| Cash Income Tax Paid | -20.57K | -20.57K | 46.00K | 72.00K | 23.00K | 441.00K |
| Change in Working Capital | -5.31M | -5.31M | -4.70M | -3.70M | 19.79M | -3.10M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 242.26M | 306.47M | 248.81M | 171.67M | 240.73M | 290.99M |
| Enterprise Value | 368.52M | 472.47M | 418.93M | 304.52M | 394.87M | 424.37M |
| Last Close Price | 6.40 | 8.18 | 6.72 | 5.62 | 7.94 | 9.87 |
| PE Ratio | 14.29 | |||||
| Forward PE | 8.17 | 8.17 | 25.55 | 167.00 | 250.59 | |
| PS Ratio | 1.87 | 2.37 | 1.93 | 1.34 | 2.33 | 2.62 |
| PB Ratio | 7.11 | 9.00 | 5.25 | 3.19 | 6.86 | 3.31 |
| P/TBV Ratio | 4.17 | |||||
| P/FCF Ratio | 38.89 | 49.20 | ||||
| P/OCF Ratio | 19.28 | 24.39 | 667.99 | |||
| PEG Ratio | 25.06 | 25.06 | 25.06 | 25.06 | 25.06 | |
| EV/Sales Ratio | 2.85 | 3.65 | 3.25 | 2.37 | 3.82 | 3.81 |
| EV/EBITDA Ratio | 44.71 | 57.32 | 123.49 | 29.82 | ||
| EV/FCF Ratio | 59.15 | 75.84 | ||||
| Debt / Equity Ratio | 4.22 | 4.22 | 2.76 | 2.39 | 3.21 | 1.71 |
| Debt / EBITDA Ratio | 16.83 | 16.83 | 43.34 | 9.63 | ||
| Debt / FCF Ratio | 23.07 | 23.07 | ||||
| Net Debt / Equity Ratio | 3.71 | 3.71 | 2.58 | 2.23 | 2.67 | 1.70 |
| Net Debt / EBITDA Ratio | 15.32 | 15.32 | -30.80 | 48.73 | -13.28 | 10.49 |
| Net Debt / FCF Ratio | 20.27 | 20.27 | -9.00 | -6.62 | -2.40 | -2.84 |
| Asset Turnover | 0.52 | 0.51 | 0.39 | 0.29 | ||
| Inventory Turnover | 2.45 | 2.14 | 1.96 | 1.46 | ||
| Quick Ratio | 2.18 | 2.18 | 1.46 | 1.02 | 1.23 | 0.22 |
| Current Ratio | 3.49 | 3.49 | 2.84 | 2.08 | 2.39 | 0.66 |
| Return on Equity (ROE) | -76.41% | 20.97% | -104.52% | -10.65% | ||
| Return on Assets (ROA) | -3.04% | -1.35% | -4.67% | -0.55% | ||
| Return on Invested Capital (ROIC) | -0.76% | -0.76% | -6.98% | -3.56% | -10.79% | -1.05% |
| Return on Capital Employed (ROCE) | -0.60% | -0.60% | -5.70% | -2.60% | -9.20% | -3.50% |
| Earnings Yield | -14.46% | -10.05% | -15.56% | 7.00% | -41.36% | -40.11% |
| FCF Yield | 2.57% | 2.03% | -5.47% | -10.56% | -16.17% | -18.05% |
| Buyback Yield / Dilution | -1.63% | -7.33% | 5.02% | -22.36% | -1.67% | -0.59% |